Loading...
Loading...
Application 2151561 · Registered
| Application Number | 2151561 |
| Status | Registered |
| Owner | teva pharmaceutical industries ltd |
| Type | trade_mark |
| Filed | 2021-01-27 |
| Registered | 2021-09-06 |
Yes. Sitagliptin-Teva is a currently protected Australian trademark. It is enforceable under the Trade Marks Act 1995 (Cth) in Australia.
Key events recorded against this trademark at IP Australia, oldest first.
| Name | teva pharmaceutical industries ltd |
| ABN | 98002951877 |
| Country | IL |
This trademark is represented by ip gateway patent & trade mark attorneys pty ltd, QLD, AU.
'Sitagliptin-Teva' is a protected trademark on the IP Australia register, owned by teva pharmaceutical industries ltd. The application (2151561) was filed on 27 January 2021 and registered on 6 September 2021.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
Australian trademark 2151561 for the mark 'Sitagliptin-Teva' in Class 5 is recorded on the IP Australia register as owned by teva pharmaceutical industries ltd. This covers one specific Australian trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the IP Australia records the status of Australian trademark 2151561 for the mark 'Sitagliptin-Teva' as protected.
Australian trademark 2151561 for the mark 'Sitagliptin-Teva' is registered in Class 5, which covers pharmaceuticals & medical preparations.
Australian trademark 2151561 for the mark 'Sitagliptin-Teva' was filed at the IP Australia on 27 January 2021 and registered on 6 September 2021.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence. Local copy last synchronised on 2026-05-03.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.